![]() | ||
|
Immunology
Infectious Disease Neuroscience Education Alzheimer’s Protein Links Nerve Cell Death and Cancer Stem Cells and Immune Memory Cells Share Self-renewal Program Molecule Shapes Up Cell Organelle HMS Academy Announces New Center for Teaching and Learning Chief Medical Officer Named in Cancer Care Countway Exhibits Changing Face of Medicine Appointments to Full Professor |
NEUROSCIENCE
|
|
|
“The exciting thing about this study is that it puts most of the elements in place—binding, functionality, and some signaling.” |
The researchers teased out the roles of these molecules by observing neuromuscular-junction growth in gain- and loss-of-function mutants. The team focused on the relationship between the LAR receptor and two Drosophila HSPGs, syndecan (Sdc) and the glycosylphosphatidylinositol-anchored glypican Dallylike (Dlp). Compared with wild types, mutant drosophila lacking Sdc developed significantly fewer boutons, the bulb-shaped heads of axons that form one side of a synaptic junction, suggesting that Sdc drives the normal development of boutons. Mutants lacking Dlp showed increased electrophysiological activity compared with wild types given similar nerve stimulation. The researchers found that the Dlp mutants formed smaller, more densely packed active zones, sites on the bouton membrane that determine the flow of neurotransmitters. This observation suggests that Dlp dictates the development of active zones and possibly the level of electrophysiological signaling.
Having shown that Sdc regulates bouton formation and Dlp regulates the functionality of the bouton, the next step was to determine the mechanism through which these HSPGs act. Cell surface binding assays showed that both Sdc and Dlp bind to LAR and revealed one other curious detail. “It seems that Dlp wins the binding competition and outcompetes Sdc for the attention of LAR,” said co–first author Alan Tenney, HMS research fellow in cell biology. Further genetic experiments using LAR-deficient mutants suggested that Sdc activates LAR and Dlp antagonizes the receptor. “This evidence suggests that LAR’s first priority may be active zone construction,” said Van Vactor.
Rules of Order
Taking these findings into account, Van Vactor proposes one possible
model of synapse formation involving a time-dependent mechanism that
makes physical
sense the same way it makes physical sense to ice a cake after baking
it. First, an axon forms a bouton, then it adds the neurotransmitter-signaling
active zones, with LAR linking these two activities together. At the
molecular
level in the neuromuscular junction, the process begins when the LAR
receptor appears on the nerve cell surface, and Sdc in the extracellular
matrix
stimulates bouton growth. “At this point, the clock starts ticking,” said
Van Vactor. “Dlp and Sdc both vie for LAR’s attention,
but the system is set up so that Dlp always wins. It’s just a
matter of time.” This
period may naturally correspond to the time it takes to form a bouton
that is ready for active-zone development.

Image courtesy of David Van Vactor
Wiring diagram. During development, axons grow into the neuromuscular junction and send nerve endings out to form synaptic connections. When the nerve processes find a suitable target, specialized proteoglycans work to form bulb-shaped boutons and then construct active zones on their surface.
Any hypothetical model has
limitations, of course. “You can construct
a model that makes sense with three genes, but there are hundreds involved
in the system, and many haven’t been studied yet,” said
biologist Kai Zinn of the California Institute of Technology. In addition
to exploring
this and other competing models, Van Vactor’s lab is exploring
the roles these LAR signaling pathways play in adult synapse plasticity.
Their
first experiment probes whether the activity-dependent plasticity observed
at the fly neuromuscular junction requires the LAR receptor.
In addition to illuminating potential steps of synapse formation, the Neuron study brings researchers closer to understanding protein tyrosine phosphatase (PTP) receptors. PTPs have been relatively intractable when compared with their sister receptors, protein tyrosine kinases, which have been characterized in detail and exploited in targeted drug therapies. “The exciting thing about this study is that it puts most of the elements in place—binding, functionality, and some signaling,” said Flanagan. “After we understand how the biology [of PTPs] works, then we can try to understand how to tinker with it.”